Fibromyalgia Treatment Market - Global Outlook and Forecast 2022-2028
Fibromyalgia syndrome (FS) is a non-articular rheumatic disorder characterized by pain and stiffness of the musculoskeletal system and tenderness in specific sites.Fibromyalgia syndrome can be secondary to trauma, a variety of rheumatic diseases, such as osteoarthritis, rheumatoid arthritis and a variety of non-rheumatic diseases (such as hypothyroidism, malignant tumors).
This report contains market size and forecasts of Fibromyalgia Treatment in global, including the following market information:
Global Fibromyalgia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Fibromyalgia Treatment Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Fibromyalgia Treatment companies in 2021 (%)
The global Fibromyalgia Treatment market was valued at 2945.2 million in 2021 and is projected to reach US$ 3308.4 million by 2028, at a CAGR of 1.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antidepressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fibromyalgia Treatment include Eli Lilly and Company, Pfizer, Novartis AG, Allergan, Aptinyx, Prismic Pharmaceuticals, Innovative Med Concepts, Intec Pharma Ltd. and Astellas Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fibromyalgia Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fibromyalgia Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Fibromyalgia Treatment Market Segment Percentages, by Type, 2021 (%)
Global Fibromyalgia Treatment Market Segment Percentages, by Application, 2021 (%)
Global Fibromyalgia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Fibromyalgia Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Fibromyalgia Treatment revenues share in global market, 2021 (%)
Key companies Fibromyalgia Treatment sales in global market, 2017-2022 (Estimated), (KG)
Key companies Fibromyalgia Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Fibromyalgia Treatment in global, including the following market information:
Global Fibromyalgia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Fibromyalgia Treatment Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Fibromyalgia Treatment companies in 2021 (%)
The global Fibromyalgia Treatment market was valued at 2945.2 million in 2021 and is projected to reach US$ 3308.4 million by 2028, at a CAGR of 1.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antidepressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fibromyalgia Treatment include Eli Lilly and Company, Pfizer, Novartis AG, Allergan, Aptinyx, Prismic Pharmaceuticals, Innovative Med Concepts, Intec Pharma Ltd. and Astellas Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fibromyalgia Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fibromyalgia Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Fibromyalgia Treatment Market Segment Percentages, by Type, 2021 (%)
- Antidepressants
- Anticonvulsants
- Muscle Relaxants
- Narcotic Analgesics
- Non-narcotic Analgesics
Global Fibromyalgia Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospitals Pharmacies
- Clinic Pharmacy
- Retail Drug Stores
- Online Pharmacies
Global Fibromyalgia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Fibromyalgia Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Fibromyalgia Treatment revenues share in global market, 2021 (%)
Key companies Fibromyalgia Treatment sales in global market, 2017-2022 (Estimated), (KG)
Key companies Fibromyalgia Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Eli Lilly and Company
- Pfizer
- Novartis AG
- Allergan
- Aptinyx
- Prismic Pharmaceuticals
- Innovative Med Concepts
- Intec Pharma Ltd.
- Astellas Pharma
- Savella
- Sun Pharmaceutical Industries
- Mylan NV
- Teva Pharmaceutical Industries
- Daiichi Sankyo
- Forest Pharmaceuticals
- Meiji Seika Pharma
- Tonix Pharmaceuticals
- Theravance Biopharma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Fibromyalgia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fibromyalgia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL FIBROMYALGIA TREATMENT OVERALL MARKET SIZE
2.1 Global Fibromyalgia Treatment Market Size: 2021 VS 2028
2.2 Global Fibromyalgia Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Fibromyalgia Treatment Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Fibromyalgia Treatment Players in Global Market
3.2 Top Global Fibromyalgia Treatment Companies Ranked by Revenue
3.3 Global Fibromyalgia Treatment Revenue by Companies
3.4 Global Fibromyalgia Treatment Sales by Companies
3.5 Global Fibromyalgia Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Fibromyalgia Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Fibromyalgia Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fibromyalgia Treatment Players in Global Market
3.8.1 List of Global Tier 1 Fibromyalgia Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Fibromyalgia Treatment Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Fibromyalgia Treatment Market Size Markets, 2021 & 2028
4.1.2 Antidepressants
4.1.3 Anticonvulsants
4.1.4 Muscle Relaxants
4.1.5 Narcotic Analgesics
4.1.6 Non-narcotic Analgesics
4.2 By Type - Global Fibromyalgia Treatment Revenue & Forecasts
4.2.1 By Type - Global Fibromyalgia Treatment Revenue, 2017-2022
4.2.2 By Type - Global Fibromyalgia Treatment Revenue, 2023-2028
4.2.3 By Type - Global Fibromyalgia Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Fibromyalgia Treatment Sales & Forecasts
4.3.1 By Type - Global Fibromyalgia Treatment Sales, 2017-2022
4.3.2 By Type - Global Fibromyalgia Treatment Sales, 2023-2028
4.3.3 By Type - Global Fibromyalgia Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Fibromyalgia Treatment Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Fibromyalgia Treatment Market Size, 2021 & 2028
5.1.2 Hospitals Pharmacies
5.1.3 Clinic Pharmacy
5.1.4 Retail Drug Stores
5.1.5 Online Pharmacies
5.2 By Application - Global Fibromyalgia Treatment Revenue & Forecasts
5.2.1 By Application - Global Fibromyalgia Treatment Revenue, 2017-2022
5.2.2 By Application - Global Fibromyalgia Treatment Revenue, 2023-2028
5.2.3 By Application - Global Fibromyalgia Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Fibromyalgia Treatment Sales & Forecasts
5.3.1 By Application - Global Fibromyalgia Treatment Sales, 2017-2022
5.3.2 By Application - Global Fibromyalgia Treatment Sales, 2023-2028
5.3.3 By Application - Global Fibromyalgia Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Fibromyalgia Treatment Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Fibromyalgia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Fibromyalgia Treatment Revenue & Forecasts
6.2.1 By Region - Global Fibromyalgia Treatment Revenue, 2017-2022
6.2.2 By Region - Global Fibromyalgia Treatment Revenue, 2023-2028
6.2.3 By Region - Global Fibromyalgia Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Fibromyalgia Treatment Sales & Forecasts
6.3.1 By Region - Global Fibromyalgia Treatment Sales, 2017-2022
6.3.2 By Region - Global Fibromyalgia Treatment Sales, 2023-2028
6.3.3 By Region - Global Fibromyalgia Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Fibromyalgia Treatment Revenue, 2017-2028
6.4.2 By Country - North America Fibromyalgia Treatment Sales, 2017-2028
6.4.3 US Fibromyalgia Treatment Market Size, 2017-2028
6.4.4 Canada Fibromyalgia Treatment Market Size, 2017-2028
6.4.5 Mexico Fibromyalgia Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Fibromyalgia Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Fibromyalgia Treatment Sales, 2017-2028
6.5.3 Germany Fibromyalgia Treatment Market Size, 2017-2028
6.5.4 France Fibromyalgia Treatment Market Size, 2017-2028
6.5.5 U.K. Fibromyalgia Treatment Market Size, 2017-2028
6.5.6 Italy Fibromyalgia Treatment Market Size, 2017-2028
6.5.7 Russia Fibromyalgia Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Fibromyalgia Treatment Market Size, 2017-2028
6.5.9 Benelux Fibromyalgia Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Fibromyalgia Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Fibromyalgia Treatment Sales, 2017-2028
6.6.3 China Fibromyalgia Treatment Market Size, 2017-2028
6.6.4 Japan Fibromyalgia Treatment Market Size, 2017-2028
6.6.5 South Korea Fibromyalgia Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Fibromyalgia Treatment Market Size, 2017-2028
6.6.7 India Fibromyalgia Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Fibromyalgia Treatment Revenue, 2017-2028
6.7.2 By Country - South America Fibromyalgia Treatment Sales, 2017-2028
6.7.3 Brazil Fibromyalgia Treatment Market Size, 2017-2028
6.7.4 Argentina Fibromyalgia Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Fibromyalgia Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Fibromyalgia Treatment Sales, 2017-2028
6.8.3 Turkey Fibromyalgia Treatment Market Size, 2017-2028
6.8.4 Israel Fibromyalgia Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Fibromyalgia Treatment Market Size, 2017-2028
6.8.6 UAE Fibromyalgia Treatment Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Corporate Summary
7.1.2 Eli Lilly and Company Business Overview
7.1.3 Eli Lilly and Company Fibromyalgia Treatment Major Product Offerings
7.1.4 Eli Lilly and Company Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly and Company Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Fibromyalgia Treatment Major Product Offerings
7.2.4 Pfizer Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Novartis AG
7.3.1 Novartis AG Corporate Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Fibromyalgia Treatment Major Product Offerings
7.3.4 Novartis AG Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Novartis AG Key News
7.4 Allergan
7.4.1 Allergan Corporate Summary
7.4.2 Allergan Business Overview
7.4.3 Allergan Fibromyalgia Treatment Major Product Offerings
7.4.4 Allergan Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Allergan Key News
7.5 Aptinyx
7.5.1 Aptinyx Corporate Summary
7.5.2 Aptinyx Business Overview
7.5.3 Aptinyx Fibromyalgia Treatment Major Product Offerings
7.5.4 Aptinyx Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Aptinyx Key News
7.6 Prismic Pharmaceuticals
7.6.1 Prismic Pharmaceuticals Corporate Summary
7.6.2 Prismic Pharmaceuticals Business Overview
7.6.3 Prismic Pharmaceuticals Fibromyalgia Treatment Major Product Offerings
7.6.4 Prismic Pharmaceuticals Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Prismic Pharmaceuticals Key News
7.7 Innovative Med Concepts
7.7.1 Innovative Med Concepts Corporate Summary
7.7.2 Innovative Med Concepts Business Overview
7.7.3 Innovative Med Concepts Fibromyalgia Treatment Major Product Offerings
7.7.4 Innovative Med Concepts Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Innovative Med Concepts Key News
7.8 Intec Pharma Ltd.
7.8.1 Intec Pharma Ltd. Corporate Summary
7.8.2 Intec Pharma Ltd. Business Overview
7.8.3 Intec Pharma Ltd. Fibromyalgia Treatment Major Product Offerings
7.8.4 Intec Pharma Ltd. Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Intec Pharma Ltd. Key News
7.9 Astellas Pharma
7.9.1 Astellas Pharma Corporate Summary
7.9.2 Astellas Pharma Business Overview
7.9.3 Astellas Pharma Fibromyalgia Treatment Major Product Offerings
7.9.4 Astellas Pharma Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.9.5 Astellas Pharma Key News
7.10 Savella
7.10.1 Savella Corporate Summary
7.10.2 Savella Business Overview
7.10.3 Savella Fibromyalgia Treatment Major Product Offerings
7.10.4 Savella Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.10.5 Savella Key News
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Corporate Summary
7.11.2 Sun Pharmaceutical Industries Fibromyalgia Treatment Business Overview
7.11.3 Sun Pharmaceutical Industries Fibromyalgia Treatment Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.11.5 Sun Pharmaceutical Industries Key News
7.12 Mylan NV
7.12.1 Mylan NV Corporate Summary
7.12.2 Mylan NV Fibromyalgia Treatment Business Overview
7.12.3 Mylan NV Fibromyalgia Treatment Major Product Offerings
7.12.4 Mylan NV Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.12.5 Mylan NV Key News
7.13 Teva Pharmaceutical Industries
7.13.1 Teva Pharmaceutical Industries Corporate Summary
7.13.2 Teva Pharmaceutical Industries Fibromyalgia Treatment Business Overview
7.13.3 Teva Pharmaceutical Industries Fibromyalgia Treatment Major Product Offerings
7.13.4 Teva Pharmaceutical Industries Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.13.5 Teva Pharmaceutical Industries Key News
7.14 Daiichi Sankyo
7.14.1 Daiichi Sankyo Corporate Summary
7.14.2 Daiichi Sankyo Business Overview
7.14.3 Daiichi Sankyo Fibromyalgia Treatment Major Product Offerings
7.14.4 Daiichi Sankyo Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.14.5 Daiichi Sankyo Key News
7.15 Forest Pharmaceuticals
7.15.1 Forest Pharmaceuticals Corporate Summary
7.15.2 Forest Pharmaceuticals Business Overview
7.15.3 Forest Pharmaceuticals Fibromyalgia Treatment Major Product Offerings
7.15.4 Forest Pharmaceuticals Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.15.5 Forest Pharmaceuticals Key News
7.16 Meiji Seika Pharma
7.16.1 Meiji Seika Pharma Corporate Summary
7.16.2 Meiji Seika Pharma Business Overview
7.16.3 Meiji Seika Pharma Fibromyalgia Treatment Major Product Offerings
7.16.4 Meiji Seika Pharma Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.16.5 Meiji Seika Pharma Key News
7.17 Tonix Pharmaceuticals
7.17.1 Tonix Pharmaceuticals Corporate Summary
7.17.2 Tonix Pharmaceuticals Business Overview
7.17.3 Tonix Pharmaceuticals Fibromyalgia Treatment Major Product Offerings
7.17.4 Tonix Pharmaceuticals Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.17.5 Tonix Pharmaceuticals Key News
7.18 Theravance Biopharma
7.18.1 Theravance Biopharma Corporate Summary
7.18.2 Theravance Biopharma Business Overview
7.18.3 Theravance Biopharma Fibromyalgia Treatment Major Product Offerings
7.18.4 Theravance Biopharma Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.18.5 Theravance Biopharma Key News
8 GLOBAL FIBROMYALGIA TREATMENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Fibromyalgia Treatment Production Capacity, 2017-2028
8.2 Fibromyalgia Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Fibromyalgia Treatment Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 FIBROMYALGIA TREATMENT SUPPLY CHAIN ANALYSIS
10.1 Fibromyalgia Treatment Industry Value Chain
10.2 Fibromyalgia Treatment Upstream Market
10.3 Fibromyalgia Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fibromyalgia Treatment Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Fibromyalgia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fibromyalgia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL FIBROMYALGIA TREATMENT OVERALL MARKET SIZE
2.1 Global Fibromyalgia Treatment Market Size: 2021 VS 2028
2.2 Global Fibromyalgia Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Fibromyalgia Treatment Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Fibromyalgia Treatment Players in Global Market
3.2 Top Global Fibromyalgia Treatment Companies Ranked by Revenue
3.3 Global Fibromyalgia Treatment Revenue by Companies
3.4 Global Fibromyalgia Treatment Sales by Companies
3.5 Global Fibromyalgia Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Fibromyalgia Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Fibromyalgia Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fibromyalgia Treatment Players in Global Market
3.8.1 List of Global Tier 1 Fibromyalgia Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Fibromyalgia Treatment Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Fibromyalgia Treatment Market Size Markets, 2021 & 2028
4.1.2 Antidepressants
4.1.3 Anticonvulsants
4.1.4 Muscle Relaxants
4.1.5 Narcotic Analgesics
4.1.6 Non-narcotic Analgesics
4.2 By Type - Global Fibromyalgia Treatment Revenue & Forecasts
4.2.1 By Type - Global Fibromyalgia Treatment Revenue, 2017-2022
4.2.2 By Type - Global Fibromyalgia Treatment Revenue, 2023-2028
4.2.3 By Type - Global Fibromyalgia Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Fibromyalgia Treatment Sales & Forecasts
4.3.1 By Type - Global Fibromyalgia Treatment Sales, 2017-2022
4.3.2 By Type - Global Fibromyalgia Treatment Sales, 2023-2028
4.3.3 By Type - Global Fibromyalgia Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Fibromyalgia Treatment Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Fibromyalgia Treatment Market Size, 2021 & 2028
5.1.2 Hospitals Pharmacies
5.1.3 Clinic Pharmacy
5.1.4 Retail Drug Stores
5.1.5 Online Pharmacies
5.2 By Application - Global Fibromyalgia Treatment Revenue & Forecasts
5.2.1 By Application - Global Fibromyalgia Treatment Revenue, 2017-2022
5.2.2 By Application - Global Fibromyalgia Treatment Revenue, 2023-2028
5.2.3 By Application - Global Fibromyalgia Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Fibromyalgia Treatment Sales & Forecasts
5.3.1 By Application - Global Fibromyalgia Treatment Sales, 2017-2022
5.3.2 By Application - Global Fibromyalgia Treatment Sales, 2023-2028
5.3.3 By Application - Global Fibromyalgia Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Fibromyalgia Treatment Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Fibromyalgia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Fibromyalgia Treatment Revenue & Forecasts
6.2.1 By Region - Global Fibromyalgia Treatment Revenue, 2017-2022
6.2.2 By Region - Global Fibromyalgia Treatment Revenue, 2023-2028
6.2.3 By Region - Global Fibromyalgia Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Fibromyalgia Treatment Sales & Forecasts
6.3.1 By Region - Global Fibromyalgia Treatment Sales, 2017-2022
6.3.2 By Region - Global Fibromyalgia Treatment Sales, 2023-2028
6.3.3 By Region - Global Fibromyalgia Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Fibromyalgia Treatment Revenue, 2017-2028
6.4.2 By Country - North America Fibromyalgia Treatment Sales, 2017-2028
6.4.3 US Fibromyalgia Treatment Market Size, 2017-2028
6.4.4 Canada Fibromyalgia Treatment Market Size, 2017-2028
6.4.5 Mexico Fibromyalgia Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Fibromyalgia Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Fibromyalgia Treatment Sales, 2017-2028
6.5.3 Germany Fibromyalgia Treatment Market Size, 2017-2028
6.5.4 France Fibromyalgia Treatment Market Size, 2017-2028
6.5.5 U.K. Fibromyalgia Treatment Market Size, 2017-2028
6.5.6 Italy Fibromyalgia Treatment Market Size, 2017-2028
6.5.7 Russia Fibromyalgia Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Fibromyalgia Treatment Market Size, 2017-2028
6.5.9 Benelux Fibromyalgia Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Fibromyalgia Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Fibromyalgia Treatment Sales, 2017-2028
6.6.3 China Fibromyalgia Treatment Market Size, 2017-2028
6.6.4 Japan Fibromyalgia Treatment Market Size, 2017-2028
6.6.5 South Korea Fibromyalgia Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Fibromyalgia Treatment Market Size, 2017-2028
6.6.7 India Fibromyalgia Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Fibromyalgia Treatment Revenue, 2017-2028
6.7.2 By Country - South America Fibromyalgia Treatment Sales, 2017-2028
6.7.3 Brazil Fibromyalgia Treatment Market Size, 2017-2028
6.7.4 Argentina Fibromyalgia Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Fibromyalgia Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Fibromyalgia Treatment Sales, 2017-2028
6.8.3 Turkey Fibromyalgia Treatment Market Size, 2017-2028
6.8.4 Israel Fibromyalgia Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Fibromyalgia Treatment Market Size, 2017-2028
6.8.6 UAE Fibromyalgia Treatment Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Corporate Summary
7.1.2 Eli Lilly and Company Business Overview
7.1.3 Eli Lilly and Company Fibromyalgia Treatment Major Product Offerings
7.1.4 Eli Lilly and Company Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly and Company Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Fibromyalgia Treatment Major Product Offerings
7.2.4 Pfizer Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Novartis AG
7.3.1 Novartis AG Corporate Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Fibromyalgia Treatment Major Product Offerings
7.3.4 Novartis AG Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Novartis AG Key News
7.4 Allergan
7.4.1 Allergan Corporate Summary
7.4.2 Allergan Business Overview
7.4.3 Allergan Fibromyalgia Treatment Major Product Offerings
7.4.4 Allergan Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Allergan Key News
7.5 Aptinyx
7.5.1 Aptinyx Corporate Summary
7.5.2 Aptinyx Business Overview
7.5.3 Aptinyx Fibromyalgia Treatment Major Product Offerings
7.5.4 Aptinyx Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Aptinyx Key News
7.6 Prismic Pharmaceuticals
7.6.1 Prismic Pharmaceuticals Corporate Summary
7.6.2 Prismic Pharmaceuticals Business Overview
7.6.3 Prismic Pharmaceuticals Fibromyalgia Treatment Major Product Offerings
7.6.4 Prismic Pharmaceuticals Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Prismic Pharmaceuticals Key News
7.7 Innovative Med Concepts
7.7.1 Innovative Med Concepts Corporate Summary
7.7.2 Innovative Med Concepts Business Overview
7.7.3 Innovative Med Concepts Fibromyalgia Treatment Major Product Offerings
7.7.4 Innovative Med Concepts Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Innovative Med Concepts Key News
7.8 Intec Pharma Ltd.
7.8.1 Intec Pharma Ltd. Corporate Summary
7.8.2 Intec Pharma Ltd. Business Overview
7.8.3 Intec Pharma Ltd. Fibromyalgia Treatment Major Product Offerings
7.8.4 Intec Pharma Ltd. Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Intec Pharma Ltd. Key News
7.9 Astellas Pharma
7.9.1 Astellas Pharma Corporate Summary
7.9.2 Astellas Pharma Business Overview
7.9.3 Astellas Pharma Fibromyalgia Treatment Major Product Offerings
7.9.4 Astellas Pharma Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.9.5 Astellas Pharma Key News
7.10 Savella
7.10.1 Savella Corporate Summary
7.10.2 Savella Business Overview
7.10.3 Savella Fibromyalgia Treatment Major Product Offerings
7.10.4 Savella Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.10.5 Savella Key News
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Corporate Summary
7.11.2 Sun Pharmaceutical Industries Fibromyalgia Treatment Business Overview
7.11.3 Sun Pharmaceutical Industries Fibromyalgia Treatment Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.11.5 Sun Pharmaceutical Industries Key News
7.12 Mylan NV
7.12.1 Mylan NV Corporate Summary
7.12.2 Mylan NV Fibromyalgia Treatment Business Overview
7.12.3 Mylan NV Fibromyalgia Treatment Major Product Offerings
7.12.4 Mylan NV Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.12.5 Mylan NV Key News
7.13 Teva Pharmaceutical Industries
7.13.1 Teva Pharmaceutical Industries Corporate Summary
7.13.2 Teva Pharmaceutical Industries Fibromyalgia Treatment Business Overview
7.13.3 Teva Pharmaceutical Industries Fibromyalgia Treatment Major Product Offerings
7.13.4 Teva Pharmaceutical Industries Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.13.5 Teva Pharmaceutical Industries Key News
7.14 Daiichi Sankyo
7.14.1 Daiichi Sankyo Corporate Summary
7.14.2 Daiichi Sankyo Business Overview
7.14.3 Daiichi Sankyo Fibromyalgia Treatment Major Product Offerings
7.14.4 Daiichi Sankyo Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.14.5 Daiichi Sankyo Key News
7.15 Forest Pharmaceuticals
7.15.1 Forest Pharmaceuticals Corporate Summary
7.15.2 Forest Pharmaceuticals Business Overview
7.15.3 Forest Pharmaceuticals Fibromyalgia Treatment Major Product Offerings
7.15.4 Forest Pharmaceuticals Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.15.5 Forest Pharmaceuticals Key News
7.16 Meiji Seika Pharma
7.16.1 Meiji Seika Pharma Corporate Summary
7.16.2 Meiji Seika Pharma Business Overview
7.16.3 Meiji Seika Pharma Fibromyalgia Treatment Major Product Offerings
7.16.4 Meiji Seika Pharma Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.16.5 Meiji Seika Pharma Key News
7.17 Tonix Pharmaceuticals
7.17.1 Tonix Pharmaceuticals Corporate Summary
7.17.2 Tonix Pharmaceuticals Business Overview
7.17.3 Tonix Pharmaceuticals Fibromyalgia Treatment Major Product Offerings
7.17.4 Tonix Pharmaceuticals Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.17.5 Tonix Pharmaceuticals Key News
7.18 Theravance Biopharma
7.18.1 Theravance Biopharma Corporate Summary
7.18.2 Theravance Biopharma Business Overview
7.18.3 Theravance Biopharma Fibromyalgia Treatment Major Product Offerings
7.18.4 Theravance Biopharma Fibromyalgia Treatment Sales and Revenue in Global (2017-2022)
7.18.5 Theravance Biopharma Key News
8 GLOBAL FIBROMYALGIA TREATMENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Fibromyalgia Treatment Production Capacity, 2017-2028
8.2 Fibromyalgia Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Fibromyalgia Treatment Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 FIBROMYALGIA TREATMENT SUPPLY CHAIN ANALYSIS
10.1 Fibromyalgia Treatment Industry Value Chain
10.2 Fibromyalgia Treatment Upstream Market
10.3 Fibromyalgia Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fibromyalgia Treatment Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Fibromyalgia Treatment in Global Market
Table 2. Top Fibromyalgia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Fibromyalgia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Fibromyalgia Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Fibromyalgia Treatment Sales by Companies, (KG), 2017-2022
Table 6. Global Fibromyalgia Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Fibromyalgia Treatment Price (2017-2022) & (USD/KG)
Table 8. Global Manufacturers Fibromyalgia Treatment Product Type
Table 9. List of Global Tier 1 Fibromyalgia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fibromyalgia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Fibromyalgia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Fibromyalgia Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Fibromyalgia Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Fibromyalgia Treatment Sales (KG), 2017-2022
Table 15. By Type - Global Fibromyalgia Treatment Sales (KG), 2023-2028
Table 16. By Application – Global Fibromyalgia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Fibromyalgia Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Fibromyalgia Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Fibromyalgia Treatment Sales (KG), 2017-2022
Table 20. By Application - Global Fibromyalgia Treatment Sales (KG), 2023-2028
Table 21. By Region – Global Fibromyalgia Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Fibromyalgia Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Fibromyalgia Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Fibromyalgia Treatment Sales (KG), 2017-2022
Table 25. By Region - Global Fibromyalgia Treatment Sales (KG), 2023-2028
Table 26. By Country - North America Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Fibromyalgia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Fibromyalgia Treatment Sales, (KG), 2017-2022
Table 29. By Country - North America Fibromyalgia Treatment Sales, (KG), 2023-2028
Table 30. By Country - Europe Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Fibromyalgia Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Fibromyalgia Treatment Sales, (KG), 2017-2022
Table 33. By Country - Europe Fibromyalgia Treatment Sales, (KG), 2023-2028
Table 34. By Region - Asia Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Fibromyalgia Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Fibromyalgia Treatment Sales, (KG), 2017-2022
Table 37. By Region - Asia Fibromyalgia Treatment Sales, (KG), 2023-2028
Table 38. By Country - South America Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Fibromyalgia Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Fibromyalgia Treatment Sales, (KG), 2017-2022
Table 41. By Country - South America Fibromyalgia Treatment Sales, (KG), 2023-2028
Table 42. By Country - Middle East & Africa Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Fibromyalgia Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Fibromyalgia Treatment Sales, (KG), 2017-2022
Table 45. By Country - Middle East & Africa Fibromyalgia Treatment Sales, (KG), 2023-2028
Table 46. Eli Lilly and Company Corporate Summary
Table 47. Eli Lilly and Company Fibromyalgia Treatment Product Offerings
Table 48. Eli Lilly and Company Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Fibromyalgia Treatment Product Offerings
Table 51. Pfizer Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 52. Novartis AG Corporate Summary
Table 53. Novartis AG Fibromyalgia Treatment Product Offerings
Table 54. Novartis AG Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 55. Allergan Corporate Summary
Table 56. Allergan Fibromyalgia Treatment Product Offerings
Table 57. Allergan Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 58. Aptinyx Corporate Summary
Table 59. Aptinyx Fibromyalgia Treatment Product Offerings
Table 60. Aptinyx Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 61. Prismic Pharmaceuticals Corporate Summary
Table 62. Prismic Pharmaceuticals Fibromyalgia Treatment Product Offerings
Table 63. Prismic Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 64. Innovative Med Concepts Corporate Summary
Table 65. Innovative Med Concepts Fibromyalgia Treatment Product Offerings
Table 66. Innovative Med Concepts Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 67. Intec Pharma Ltd. Corporate Summary
Table 68. Intec Pharma Ltd. Fibromyalgia Treatment Product Offerings
Table 69. Intec Pharma Ltd. Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 70. Astellas Pharma Corporate Summary
Table 71. Astellas Pharma Fibromyalgia Treatment Product Offerings
Table 72. Astellas Pharma Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 73. Savella Corporate Summary
Table 74. Savella Fibromyalgia Treatment Product Offerings
Table 75. Savella Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 76. Sun Pharmaceutical Industries Corporate Summary
Table 77. Sun Pharmaceutical Industries Fibromyalgia Treatment Product Offerings
Table 78. Sun Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 79. Mylan NV Corporate Summary
Table 80. Mylan NV Fibromyalgia Treatment Product Offerings
Table 81. Mylan NV Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 82. Teva Pharmaceutical Industries Corporate Summary
Table 83. Teva Pharmaceutical Industries Fibromyalgia Treatment Product Offerings
Table 84. Teva Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 85. Daiichi Sankyo Corporate Summary
Table 86. Daiichi Sankyo Fibromyalgia Treatment Product Offerings
Table 87. Daiichi Sankyo Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 88. Forest Pharmaceuticals Corporate Summary
Table 89. Forest Pharmaceuticals Fibromyalgia Treatment Product Offerings
Table 90. Forest Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 91. Meiji Seika Pharma Corporate Summary
Table 92. Meiji Seika Pharma Fibromyalgia Treatment Product Offerings
Table 93. Meiji Seika Pharma Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 94. Tonix Pharmaceuticals Corporate Summary
Table 95. Tonix Pharmaceuticals Fibromyalgia Treatment Product Offerings
Table 96. Tonix Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 97. Theravance Biopharma Corporate Summary
Table 98. Theravance Biopharma Fibromyalgia Treatment Product Offerings
Table 99. Theravance Biopharma Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 100. Fibromyalgia Treatment Production Capacity (KG) of Key Manufacturers in Global Market, 2020-2022 (KG)
Table 101. Global Fibromyalgia Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 102. Global Fibromyalgia Treatment Production by Region, 2017-2022 (KG)
Table 103. Global Fibromyalgia Treatment Production by Region, 2023-2028 (KG)
Table 104. Fibromyalgia Treatment Market Opportunities & Trends in Global Market
Table 105. Fibromyalgia Treatment Market Drivers in Global Market
Table 106. Fibromyalgia Treatment Market Restraints in Global Market
Table 107. Fibromyalgia Treatment Raw Materials
Table 108. Fibromyalgia Treatment Raw Materials Suppliers in Global Market
Table 109. Typical Fibromyalgia Treatment Downstream
Table 110. Fibromyalgia Treatment Downstream Clients in Global Market
Table 111. Fibromyalgia Treatment Distributors and Sales Agents in Global Market
Table 1. Key Players of Fibromyalgia Treatment in Global Market
Table 2. Top Fibromyalgia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Fibromyalgia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Fibromyalgia Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Fibromyalgia Treatment Sales by Companies, (KG), 2017-2022
Table 6. Global Fibromyalgia Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Fibromyalgia Treatment Price (2017-2022) & (USD/KG)
Table 8. Global Manufacturers Fibromyalgia Treatment Product Type
Table 9. List of Global Tier 1 Fibromyalgia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fibromyalgia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Fibromyalgia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Fibromyalgia Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Fibromyalgia Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Fibromyalgia Treatment Sales (KG), 2017-2022
Table 15. By Type - Global Fibromyalgia Treatment Sales (KG), 2023-2028
Table 16. By Application – Global Fibromyalgia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Fibromyalgia Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Fibromyalgia Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Fibromyalgia Treatment Sales (KG), 2017-2022
Table 20. By Application - Global Fibromyalgia Treatment Sales (KG), 2023-2028
Table 21. By Region – Global Fibromyalgia Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Fibromyalgia Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Fibromyalgia Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Fibromyalgia Treatment Sales (KG), 2017-2022
Table 25. By Region - Global Fibromyalgia Treatment Sales (KG), 2023-2028
Table 26. By Country - North America Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Fibromyalgia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Fibromyalgia Treatment Sales, (KG), 2017-2022
Table 29. By Country - North America Fibromyalgia Treatment Sales, (KG), 2023-2028
Table 30. By Country - Europe Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Fibromyalgia Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Fibromyalgia Treatment Sales, (KG), 2017-2022
Table 33. By Country - Europe Fibromyalgia Treatment Sales, (KG), 2023-2028
Table 34. By Region - Asia Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Fibromyalgia Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Fibromyalgia Treatment Sales, (KG), 2017-2022
Table 37. By Region - Asia Fibromyalgia Treatment Sales, (KG), 2023-2028
Table 38. By Country - South America Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Fibromyalgia Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Fibromyalgia Treatment Sales, (KG), 2017-2022
Table 41. By Country - South America Fibromyalgia Treatment Sales, (KG), 2023-2028
Table 42. By Country - Middle East & Africa Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Fibromyalgia Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Fibromyalgia Treatment Sales, (KG), 2017-2022
Table 45. By Country - Middle East & Africa Fibromyalgia Treatment Sales, (KG), 2023-2028
Table 46. Eli Lilly and Company Corporate Summary
Table 47. Eli Lilly and Company Fibromyalgia Treatment Product Offerings
Table 48. Eli Lilly and Company Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Fibromyalgia Treatment Product Offerings
Table 51. Pfizer Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 52. Novartis AG Corporate Summary
Table 53. Novartis AG Fibromyalgia Treatment Product Offerings
Table 54. Novartis AG Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 55. Allergan Corporate Summary
Table 56. Allergan Fibromyalgia Treatment Product Offerings
Table 57. Allergan Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 58. Aptinyx Corporate Summary
Table 59. Aptinyx Fibromyalgia Treatment Product Offerings
Table 60. Aptinyx Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 61. Prismic Pharmaceuticals Corporate Summary
Table 62. Prismic Pharmaceuticals Fibromyalgia Treatment Product Offerings
Table 63. Prismic Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 64. Innovative Med Concepts Corporate Summary
Table 65. Innovative Med Concepts Fibromyalgia Treatment Product Offerings
Table 66. Innovative Med Concepts Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 67. Intec Pharma Ltd. Corporate Summary
Table 68. Intec Pharma Ltd. Fibromyalgia Treatment Product Offerings
Table 69. Intec Pharma Ltd. Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 70. Astellas Pharma Corporate Summary
Table 71. Astellas Pharma Fibromyalgia Treatment Product Offerings
Table 72. Astellas Pharma Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 73. Savella Corporate Summary
Table 74. Savella Fibromyalgia Treatment Product Offerings
Table 75. Savella Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 76. Sun Pharmaceutical Industries Corporate Summary
Table 77. Sun Pharmaceutical Industries Fibromyalgia Treatment Product Offerings
Table 78. Sun Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 79. Mylan NV Corporate Summary
Table 80. Mylan NV Fibromyalgia Treatment Product Offerings
Table 81. Mylan NV Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 82. Teva Pharmaceutical Industries Corporate Summary
Table 83. Teva Pharmaceutical Industries Fibromyalgia Treatment Product Offerings
Table 84. Teva Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 85. Daiichi Sankyo Corporate Summary
Table 86. Daiichi Sankyo Fibromyalgia Treatment Product Offerings
Table 87. Daiichi Sankyo Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 88. Forest Pharmaceuticals Corporate Summary
Table 89. Forest Pharmaceuticals Fibromyalgia Treatment Product Offerings
Table 90. Forest Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 91. Meiji Seika Pharma Corporate Summary
Table 92. Meiji Seika Pharma Fibromyalgia Treatment Product Offerings
Table 93. Meiji Seika Pharma Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 94. Tonix Pharmaceuticals Corporate Summary
Table 95. Tonix Pharmaceuticals Fibromyalgia Treatment Product Offerings
Table 96. Tonix Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 97. Theravance Biopharma Corporate Summary
Table 98. Theravance Biopharma Fibromyalgia Treatment Product Offerings
Table 99. Theravance Biopharma Fibromyalgia Treatment Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 100. Fibromyalgia Treatment Production Capacity (KG) of Key Manufacturers in Global Market, 2020-2022 (KG)
Table 101. Global Fibromyalgia Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 102. Global Fibromyalgia Treatment Production by Region, 2017-2022 (KG)
Table 103. Global Fibromyalgia Treatment Production by Region, 2023-2028 (KG)
Table 104. Fibromyalgia Treatment Market Opportunities & Trends in Global Market
Table 105. Fibromyalgia Treatment Market Drivers in Global Market
Table 106. Fibromyalgia Treatment Market Restraints in Global Market
Table 107. Fibromyalgia Treatment Raw Materials
Table 108. Fibromyalgia Treatment Raw Materials Suppliers in Global Market
Table 109. Typical Fibromyalgia Treatment Downstream
Table 110. Fibromyalgia Treatment Downstream Clients in Global Market
Table 111. Fibromyalgia Treatment Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Fibromyalgia Treatment Segment by Type
Figure 2. Fibromyalgia Treatment Segment by Application
Figure 3. Global Fibromyalgia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Fibromyalgia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Fibromyalgia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Fibromyalgia Treatment Sales in Global Market: 2017-2028 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Fibromyalgia Treatment Revenue in 2021
Figure 9. By Type - Global Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Fibromyalgia Treatment Price (USD/KG), 2017-2028
Figure 12. By Application - Global Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Fibromyalgia Treatment Price (USD/KG), 2017-2028
Figure 15. By Region - Global Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 19. US Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 24. Germany Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 33. China Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Fibromyalgia Treatment Production Capacity (KG), 2017-2028
Figure 49. The Percentage of Production Fibromyalgia Treatment by Region, 2021 VS 2028
Figure 50. Fibromyalgia Treatment Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Fibromyalgia Treatment Segment by Type
Figure 2. Fibromyalgia Treatment Segment by Application
Figure 3. Global Fibromyalgia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Fibromyalgia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Fibromyalgia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Fibromyalgia Treatment Sales in Global Market: 2017-2028 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Fibromyalgia Treatment Revenue in 2021
Figure 9. By Type - Global Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Fibromyalgia Treatment Price (USD/KG), 2017-2028
Figure 12. By Application - Global Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Fibromyalgia Treatment Price (USD/KG), 2017-2028
Figure 15. By Region - Global Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 19. US Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 24. Germany Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 33. China Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Fibromyalgia Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Fibromyalgia Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Fibromyalgia Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Fibromyalgia Treatment Production Capacity (KG), 2017-2028
Figure 49. The Percentage of Production Fibromyalgia Treatment by Region, 2021 VS 2028
Figure 50. Fibromyalgia Treatment Industry Value Chain
Figure 51. Marketing Channels
